← Back to Clinical Trials
RecruitingNCT04794595
Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionSepsis
SponsorChildren's Hospital of Fudan University
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment90
SexALL
Min Age28 Days
Max Age18 Years
Start Date2020-12-01
Completion2026-12-30
All Conditions
Interventions
CBP
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.
Eligibility Criteria
Inclusion Criteria: * Age of 29d to 18 years old; * Children diagnosed with sepsis requiring blood purification. Exclusion Criteria: * with a history of a duration of PICU stay \<24 h * active bleeding, including cerebral hemorrhage
Related Trials
NCT04961580
PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection
View Trial →
NCT04513288
ICITRU : Randomized Trial of Immunonutrition With L-citrulline in Patients Hospitalized in Intensive
View Trial →
NCT05136560
Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology